T1	Participants 114 165	stage III colon cancer (NCCTG N0147 Clinical Trial)
T2	Participants 492 585	patients with stage III colon cancer who enrolled in a phase III clinical trial (NCCTG N0147)
T3	Participants 1891 1921	patients with stage III tumors
